Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 22, 2014
Jeanne Tung, M.D., a pediatric gastroenterologist at Mayo Clinic, discusses a recent study published in the Inflammatory Bowel Diseases Journal about infliximab therapy for pediatric IBD patients. The study shows that the use of infliximab in pediatric Crohn's disease and ulcerative colitis is limited beyond one year.